De
Da
En
Fr
Sv
Deal History
Über uns
Die Firma
Team
Büros
Globalscope
Newsletter
Services
Corporate Finance
Debt Advisory
Aktienanalyse
Growth Equity
IPO Strategie und Vorbereitung
Industries
Business Services
Consumer & Internet
Industrial Technology
Life Science
Software & TMT
Energy & Infrastructure
Research
Equity Research
Märkte
Karriere
Events
Insights
News
Company News
Deal News
In den Medien
Newsletter
Kontakt
Newsletter
De
Da
En
Fr
Sv
Main menu button
Worldwide
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Team
Deals
Kontakt
Worldwide
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Team
Deals
Kontakt
News
Alle
Abera Bioscience
Adventure Box
Adverty
All for One Group
ALM Equity
Alzecure Pharma
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CellaVision
CSAM Health Group
DanCann Pharma
Ecoclime
Elicera Therapeutics
Enrad
Frequentis
FRISQ
Future Gaming
GHP Specialty Care
GIAB
H&D Wireless
Hanza
Herantis Pharma
InCoax
Kancera
Medclair Invest
Midsummer
Mindark PE
Modus Therapeutics
Moninvent
NeoDynamics
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Pharmiva
Raytelligence
Risk Intelligence
SBB i Norden
Sensec
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Jetty
Viva Wine Group
Ytrade Group
Zazz Energy
Zinzino
Alle
Company News
Deal News
Equity Research
Events
In den Medien
Insights
Märkte
04 Jul 2024
Equity research Zinzino: Solid growth in Q2 and M&A on the agenda
Equity Research
Zinzino
26 Jun 2024
Mrkt BUZZ InCoax: Financial targets underpin our growth expectations
Equity Research
InCoax
20 Jun 2024
Equity Research Nosa Plugs: New orders and distributor agreements
Equity Research
Nosa Plugs
20 Jun 2024
Equity research Artificial Solutions: Improved financial strength and proven investor interest
Equity Research
Teneo AI
20 Jun 2024
Equity research Svenska Aerogel: New pilot orders and improved finances
Equity Research
Svenska Aerogel
11 Jun 2024
Equity Research Biosergen: Study permission received, BSG005 ready for testing in patients
Equity Research
Biosergen
10 Jun 2024
Equity research Enrad: Continued strong order intake bodes well for 2024
Equity Research
Enrad
10 Jun 2024
Equity research, Artificial Solutions: Enabling contact centre excellence through AI
Equity Research
Teneo AI
03 Jun 2024
Equity Research ALM Equity, Q1 2024: 30% NAV discount after price fall
Equity Research
ALM Equity
31 Mai 2024
Equity research Abera Bioscience: Bird flu cases put vaccine companies in the spotlight
Equity Research
Abera Bioscience
30 Mai 2024
Equity Research ALM Equity, Q1 2024: Improved gross profit despite lower sales
Equity Research
ALM Equity
23 Mai 2024
Equity research Abera Bioscience Q1 2024: Increased focus on new projects
Equity Research
Abera Bioscience
23 Mai 2024
Equity research Zinzino, Q1 2024: Solid growth outlook confirmed
Equity Research
Zinzino
22 Mai 2024
Equity research Zinzino, Q1 2024: Growth and some scalability
Equity Research
Zinzino
22 Mai 2024
Carlsquare weekly market letter: Commodity bull run– when will it affect inflation?
Equity Research
Carlsquare
21 Mai 2024
Equity Research GIAB, Q1 2024: Third savings programme to break even
Equity Research
GIAB
20 Mai 2024
Equity Research Ecoclime, Q1 2024: Sales growth possible after weak quarter
Equity Research
Ecoclime
20 Mai 2024
Equity research Viva Wine Group, Q1 2024: Solid cost control improves longterm outlook
Equity Research
Viva Wine Group
17 Mai 2024
Equity research Nosa Plugs Q1, 2024: Tepid Q1 and updated company strategy
Equity Research
Nosa Plugs
16 Mai 2024
Equity Research Ecoclime Q1 2024: A weak quarter but continued growth for Evertherm
Equity Research
Ecoclime
1
2
3
4
5
…
53